Q32 Bio Inc. — Director's Dealing 2023

Jan 20, 2023

SEC Form 4/A — Form 4/A

Issuer: Homology Medicines, Inc. (FIXX)
CIK: 0001661998
Period of Report: 2023-01-09

Reporting Person: Seymour Albert (Director, See Remarks)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	147702	Direct

Footnotes

F1: This amended Form 4 is being filed to correct the aggregate common stock holdings of the Reporting Person. The common stock holdings in column 5 of Table I have been increased by 4,536 shares acquired under the Issuer's Employee Stock Purchase Plan on dates ranging from February 28, 2019 to August 31, 2021, which were previously inadvertently omitted.